Published in Adv Exp Med Biol on January 01, 1994
Reduced stents and stent-grafts for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation. Semin Intervent Radiol (2005) 0.91
Current concepts in the pathophysiology and management of hepatic encephalopathy. Gastroenterol Hepatol (N Y) (2011) 0.89
The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82
Hyperammonaemia-induced skeletal muscle mitochondrial dysfunction results in cataplerosis and oxidative stress. J Physiol (2016) 0.76
THDP17 decreases ammonia production through glutaminase inhibition. A new drug for hepatic encephalopathy therapy. PLoS One (2014) 0.75
Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions. Gut Liver (2016) 0.75
Hepatic encephalopathy. Gastroenterol Rep (Oxf) (2017) 0.75
Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J Biol Chem (1999) 1.23
Regional ketone body utilization by rat brain in starvation and diabetes. Am J Physiol (1986) 1.15
Pathology of alcoholic liver disease. VA Cooperative Study Group 119. Semin Liver Dis (1993) 1.11
Cerebral glucose use measured with [14C]glucose labeled in the 1, 2, or 6 position. Am J Physiol (1985) 1.07
Significance of megamitochondria in alcoholic liver disease. Gastroenterology (1986) 0.99
Different roles of BDNF in nucleus accumbens core versus shell during the incubation of cue-induced cocaine craving and its long-term maintenance. J Neurosci (2013) 0.97
Hereditary tumors of the carotid bodies and chronic obstructive pulmonary disease. Cancer (1974) 0.96
Hyperammonaemia causes many of the changes found after portacaval shunting. Biochem J (1990) 0.94
Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy. J Neurochem (1993) 0.93
Glucose transporter asymmetries in the bovine blood-brain barrier. J Biol Chem (2001) 0.92
Correlation of plasma and brain amino acid and putative neurotransmitter alterations during acute hepatic coma in the rat. J Neurochem (1979) 0.92
Drug hypersensitivity syndrome with lithium. Indian J Dermatol Venereol Leprol (2010) 0.91
Regional brain glutamate transport in rats at normal and raised concentrations of circulating glutamate. Cell Tissue Res (1995) 0.90
Diurnal rhythm in endoplasmic reticulum of rat liver: electron microscopic study. Science (1972) 0.89
Metabolic abnormalities and grade of encephalopathy in acute hepatic failure. J Neurochem (1994) 0.89
Longevity among ethnic groups in alcoholic liver disease. Alcohol Alcohol (1989) 0.88
Failure of glucose and branched-chain amino acids to normalize brain glucose use in portacaval shunted rats. J Neurochem (1986) 0.87
Intermittent idiopathic portal hypertension. A case report. Gastroenterology (1974) 0.87
Regional cerebral glucose utilization in rats with portacaval anastomosis. J Neurochem (1983) 0.87
"Nonalcoholic" chronic hepatitis in the alcoholic. Gastroenterology (1977) 0.86
Early establishment of cerebral dysfunction after portacaval shunting. Am J Physiol (1990) 0.85
Glucose transporters and glucose utilization in rat brain after acute ethanol administration. Metab Brain Dis (2000) 0.85
Regeneration and tolerance factor of the human placenta induces IL-10 production. Eur J Immunol (2001) 0.84
Portacaval anastomosis: brain and plasma metabolite abnormalities and the effect of nutritional therapy. J Neurochem (1984) 0.84
Hyperammonaemia does not impair brain function in the absence of net glutamine synthesis. Biochem J (1991) 0.84
Brain energy metabolism in streptozotocin-diabetes. Biochem J (1988) 0.84
Expression of regeneration and tolerance factor correlates directly with human immunodeficiency virus infection and inversely with hepatitis C virus infection. Clin Diagn Lab Immunol (2000) 0.83
Ontogenesis of cytoplasmic organelles in rat hepatocytes and the effects of prenatal phenobarbital on endoplasmic reticulum development. Dev Biol (1974) 0.82
Ultrastructural aspects of primary biliary cirrhosis and other types of cholestatic liver disease. Gastroenterology (1974) 0.81
Regional brain glucose metabolism is altered during rapid eye movement sleep in the cat: a preliminary study. J Comp Neurol (1991) 0.81
Prognostic significance of cholestatic alcoholic hepatitis. VA Cooperative Study Group #119. Dig Dis Sci (1990) 0.81
Tryptophan transport across the blood-brain barrier during acute hepatic failure. J Neurochem (1979) 0.81
Regional blood-brain barrier permeability to amino acids after portacaval anastomosis. J Neurochem (1982) 0.81
Ammonia selectively stimulates neutral amino acid transport across blood-brain barrier. Am J Physiol (1983) 0.81
Regional cerebral glucose utilization during Althesin anesthesia. Anesthesiology (1984) 0.81
Human hepatocyte growth factor in alcoholic liver disease: a comparison with change in alpha-fetoprotein. Department of Veterans Affairs Cooperative Study Group 275. Alcohol Clin Exp Res (1996) 0.80
Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. Kidney Int (1996) 0.80
Glucose availability to individual cerebral structures is correlated to glucose metabolism. J Neurochem (1983) 0.80
Comparison of [14C]glucose and [14C]deoxyglucose as tracers of brain glucose use. Am J Physiol (1988) 0.79
Penetration of glutamate into brain of 7-day-old rats. Metab Brain Dis (1997) 0.79
Regional amino acid transport into brain during diabetes: effect of plasma amino acids. Am J Physiol (1987) 0.79
Relevance of anti-HCV reactivity in patients with alcoholic hepatitis. VA cooperative Study Group #275. Gastroenterol Jpn (1993) 0.78
The influence of ketamine on regional brain glucose use. Anesthesiology (1988) 0.78
Hyperammonaemia depresses glucose consumption throughout the brain. Biochem J (1991) 0.78
Changes in brain metabolism in hepatic encephalopathy. Neurochem Pathol (1987) 0.78
Hypogammaglobulinemia and hemophagocytic syndrome associated with lymphoproliferative disorders. Cancer (1986) 0.78
Brain energy consumption in ethanol-treated, Long-Evans rats. J Nutr (1991) 0.77
Regional cerebral glucose utilization measured with [14C]glucose in brief experiments. Am J Physiol (1983) 0.77
Use of thin-layer chromatography on silica gel for serum lipid fractionation and measurement in the routine clinical laboratory. Clin Chem (1972) 0.77
Regional brain monoamines and their metabolites after portacaval shunting. Metab Brain Dis (1987) 0.77
Alpha-fetoprotein alterations in alcoholics with liver disease. V.A. Cooperative Study Groups. Alcohol Alcohol (1991) 0.77
Ischemic brain damage is not ameliorated by 1,3-butanediol in hyperglycemic rats. Stroke (1992) 0.77
Eliminating metabolic abnormalities of portacaval shunting by restoring normal liver blood flow. Am J Physiol (1996) 0.77
Pancreatic polypeptide inhibits amylase release by rat pancreatic acini. J Surg Res (1986) 0.77
Cerebral function in hepatic encephalopathy. Adv Exp Med Biol (1990) 0.76
Megamitochondria in hepatic and renal disease. Am J Gastroenterol (1980) 0.76
Morphometric study of hepatic ultrastructure in alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis. Histol Histopathol (1987) 0.76
Regional brain glucose utilization in rats during etomidate anesthesia. Anesthesiology (1986) 0.75
Regression of human cirrhosis. Arch Pathol Lab Med (2000) 0.75
Altered proline uptake by mouse liver cells after chronic exposure to ethanol and its metabolites. Gut (1984) 0.75
Optimizing the measurement of regional cerebral glucose consumption with [6-14C]glucose. J Neurosci Methods (1994) 0.75
Regional transport of some essential nutrients across the blood-brain barrier in normal and diseased states. Ann N Y Acad Sci (1988) 0.75
Comparison of the metabolic disturbances caused by end-to-side and side-to-side portacaval shunts. J Appl Physiol (1985) (1996) 0.75
Ontogenetic changes in the ultrastructure of rat hepatocyte organelles after prenatal x-irradiation. Radiat Res (1975) 0.75
The passage of neutral amino acids across the blood-brain barrier of individual brain structures in normal and encephalopathic rats. Biochem Soc Trans (1980) 0.75
Brain metabolism in hepatic encephalopathy and hyperammonemia. Adv Exp Med Biol (1993) 0.75
Peliosis hepatis. Its relationship to chronic alcoholism, aflatoxin B1, and carcinogenesis in male Holtzman rats. Dig Dis Sci (1980) 0.75
Diurnal rhythm returns to normal after elimination of portacaval shunting. Am J Physiol (1998) 0.75
[Fatal hematochezia complicating sigmoid fistulization of an aorto-iliac bypass false aneurysm]. Ann Fr Anesth Reanim (2001) 0.75
Effect of bedding changes and room ventilation rates on blood and brain ammonia levels in normal rats and rats with portacaval shunts. Lab Anim Sci (1984) 0.75
Pentobarbital-enhanced [3H]flunitrazepam binding throughout the rat brain: an autoradiographic study. J Pharmacol Exp Ther (1992) 0.75
The blood-brain barrier in encephalopathy. Lancet (1982) 0.75
Cell cycle and organelle enzyme changes in the regenerating liver of the alcoholic rat. Alcohol Alcohol (1987) 0.75
The interactions of insulin-like growth factor I(IGF-I) with protein-calorie malnutrition in patients with alcoholic liver disease: V.A. Cooperative Study on Alcoholic Hepatitis VI. Alcohol Alcohol (1989) 0.75
Brain metabolism in encephalopathy caused by hyperammonemia. Adv Exp Med Biol (1994) 0.75
Sclerosing hyaline necrosis in noncirrhotic chronic alcoholic hepatitis. Am J Clin Pathol (1976) 0.75
The ferret: a new model of oral ethanol injury involving the liver, bone marrow, and peripheral blood lymphocytes. Alcohol Clin Exp Res (1986) 0.75
Reversal of portacaval shunting normalizes brain energy consumption in most brain structures. Am J Physiol (1996) 0.75
Blood-brain barrier during portal-systemic encephalopathy. Lancet (1981) 0.75
Alcohol modulation of immune function: clinical and experimental data. Veterans Affairs Cooperative Study Groups 119 and 275. Alcohol Clin Exp Res (1995) 0.75
Barrett's esophagus and multiple malignancies. Arch Pathol Lab Med (1982) 0.75
Hormonal influences on chemical carcinogenesis: studies with the aflatoxin B1 hepatocarcinoma model in the rat. Dig Dis Sci (1980) 0.75
Regional blood-brain barrier transport of ketone bodies in portacaval-shunted rats. Am J Physiol (1991) 0.75
Erythropoietin and cytokine levels in the anemia of severe alcoholic liver disease. Alcohol Clin Exp Res (1996) 0.75
Cerebral glucose utilization in awake unstressed rats. Am J Physiol (1983) 0.75
Inhibition of hepatocarcinogenesis by adrenocorticotropin in aflatoxin B1-treated rats. J Natl Cancer Inst (1977) 0.75
Amino acid supply to individual cerebral structures in awake and anesthetized rats. Am J Physiol (1982) 0.75
Balancing accountable care with risk aversion: transplantation as a model--we cannot forget the outcomes. Am J Transplant (2013) 0.75